期刊
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
卷 29, 期 10, 页码 695-703出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/jir.2009.0003
关键词
-
资金
- Anhui Provincial Science and Technology Development Foundation project, China [06013124B]
- Anhui Provincial Natural Science Foundation [20090413117]
- National Natural Science Foundation of China [30771973, 30570704]
- US National Cancer Institute [CA105005, CA78282]
- NATIONAL CANCER INSTITUTE [R01CA105005, R01CA078282] Funding Source: NIH RePORTER
Cervical cancer is the most common malignant disease responsible for the deaths of a large number of women in the developing world. Although certain strains of human papillomavirus (HPV) have been identified as the cause of this disease, events that lead to formation of malignant tumors are not fully clear. STAT3 is a major oncogenic transcription factor involved in the development and progression of a number of human tumors. However, the mechanisms that result in loss of control over STAT3 activity are not understood. Gene associated with Retinoid-Interferon-induced Mortality-19 (GRIM-19) is a tumor-suppressive protein identified using a genetic technique in the interferon/retinoid-induced cell death pathway. Here, we show that reduction in GRIM-19 protein levels occur in a number of primary human cervical cancers. Consequently, these tumors tend to express a high basal level of STAT3 and its downstream target genes. More importantly, using a surrogate model, we show that restoration of GRIM-19 levels reestablishes the control over STAT3-dependent gene expression and tumor growth in vivo. GRIM-19 suppressed the expression of tumor invasion- and angiogenesis-associated factors to limit tumor growth. This study identifies another major novel molecular pathway inactivated during the development of human cervical cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据